| Name | Title | Contact Details |
|---|
Humedica, Inc. is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Brighton, MA. To find more information about Humedica, Inc., please visit www.humedica.com
Telesta Therapeutics is a biopharmaceutical company focused on the development, manufacturing and commercialization of transformative human therapeutics. Our main focus is on novel medicines that address major unmet medical needs, particularly in oncology. Our anchor product, MCNA, has completed a Phase III pivotal study in patients with non-muscle invasive bladder cancer that have failed the first line therapy, bacillus Calmette-Guérin (BCG). Telesta submitted a Biologics Licensing Application (BLA) for MCNA with the U.S. FDA on June 29, 2015 and is seeking, upon marketing approval in the U.S., to make MCNA available for patients and their physicians. Our ultimate goal is to transform the treatment landscape and prolong and improve the lives of those affected by bladder cancer, one of the most common types of cancers today.
Prairie View is a regional behavioral,addiction and mental health system offering a continuum of services for children, adolescents, adults and older adults. As the state`s longest-serving, non-profit behavioral health care center - and the only faith-based community mental health center - our professional staff takes pride in bringing about restoration through services that combine compassion with dignity and respect. Prairie View has five outpatient locations in Newton, east and west Wichita, Hillsboro and McPherson, and a network of behavioral health providers throughout Kansas and the Midwest. Prairie View is the community mental health center for Harvey, Marion and McPherson counties.
Community Health Group is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Chula Vista, CA. To find more information about Community Health Group, please visit www.chtsd.com
ChromaDex Corp. is a global bioscience company dedicated to healthy aging. The ChromaDex team, which includes world-renowned scientists, is pioneering research on nicotinamide adenine dinucleotide (NAD+), levels of which decline with age. ChromaDex is the innovator behind NAD+ precursor nicotinamide riboside (NR), commercialized as the flagship ingredient Niagen®. Nicotinamide riboside and other NAD+ precursors are protected by ChromaDex`s patent portfolio. ChromaDex delivers Niagen® as the sole active ingredient in its consumer product, Tru Niagen® — available at www.truniagen.com and through partnerships with global retailers and distributors.